Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Multiparity in women with multiple sclerosis causes less long-term disability: No.
Evaluation of the effects of group psychotherapy on cognitive function in patients with multiple sclerosis with cognitive dysfunction and depression.
Multiple sclerosis: Scoring system to predict response to IFN-β in patients with multiple sclerosis.
Polyarteritis nodosa with central nervous system involvement mimicking relapsing-remitting multiple sclerosis.
Disability caused by multiple sclerosis is associated with the number of extra cranial venous stenoses: possible improvement by venous angioplasty. Results of a prospective study.
Betulinic acid regulates generation of neuroinflammatory mediators responsible for tissue destruction in multiple sclerosis in vitro.
Within-lesion differences in quantitative MRI parameters predict contrast enhancement in multiple sclerosis.
Myelin membrane assembly is driven by a phase transition of myelin basic proteins into a cohesive protein meshwork.
Central nervous system involvement in primary Sjogren`s syndrome manifesting as multiple sclerosis.
Teriflunomide (Aubagio®) for the treatment of multiple sclerosis.
Neuropsychiatric Lupus: The Prevalence and Autoantibody Associations Depend on the Definition: Results from the 1000 Faces of Lupus Cohort.
The progress of cognitive decline in newly diagnosed MS patients.
The Primate EAE Model Points at EBV-Infected B Cells as a Preferential Therapy Target in Multiple Sclerosis.
Implementing technology-based embedded assessment in the home and community life of individuals aging with disabilities: a participatory research and development study.
A forgotten aspect of the NICE reference case: an observational study of the health related quality of life impact on caregivers of people with multiple sclerosis.
Dual task cost of walking is related to fall risk in persons with multiple sclerosis.
Detecting cognitive dysfunction in a busy multiple sclerosis clinical setting: a computer generated approach.
Changes in functional network centrality underlie cognitive dysfunction and physical disability in multiple sclerosis.
Phagocytosis of Microglia in the Central Nervous System Diseases.
Adipose-Derived Stem Cells Promote Peripheral Nerve Regeneration In Vivo without Differentiation into Schwann-Like Lineage.
Butyrate, neuroepigenetics and the gut microbiome: Can a high fiber diet improve brain health?
Supernumerary phantom limbs in ICU patients with acute inflammatory demyelinating polyneuropathy.
Principles of DNA-Based Gut Microbiota Assessment and Therapeutic Efficacy of Fecal Microbiota Transplantation in Gastrointestinal Diseases.
Improved spatial regression analysis of diffusion tensor imaging for lesion detection during longitudinal progression of multiple sclerosis in individual subjects.
Pituitary-ovary axis and ovarian reserve in fertile women with multiple sclerosis: A pilot study.
Pages
« first
‹ previous
…
496
497
498
499
500
501
502
503
504
…
next ›
last »